The latest news in rare cancer tumour types including sarcomas
ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refractory ewing sarcoma
Use of high-dose ifosfamide (Ifex) was found to be superior for treating recurrent and primary refractory…